Clinical Trial

Clinical Trial of Vildagliptin in Early Parkinson's Disease

Study acronym: VERY-PD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Investigating the efficacy of Vildagliptin in delaying the progression of Parkinson's disease.
Trial Details
NCT Number NCT06951334
Lead Sponsor First Affiliated Hospital, Sun Yat-Sen University
Conditions Parkinson's Disease
Enrollment 66 participants
Start Date 2025-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-30